Researcher

Pieter Cullis

Profile

Institution

University of British Columbia

Field

Biochemistry

Pieter Cullis pioneered lipid nanoparticle delivery systems that enable mRNA vaccines and RNA therapeutics. His decades of work on lipid biophysics made possible the delivery technology behind COVID-19 mRNA vaccines and several approved gene-silencing drugs.

Industry Ties

Industry Ties

Acuitas TherapeuticsPrecision NanoSystemsGenevant Sciences

Verified employment, education, publications and profile data sourced from ORCID. Locked — unlock to view.

Fields

• Biochemistry

Universities

• University of British Columbia